Acute oxalate nephropathy secondary to orlistat-induced enteric hyperoxaluria

Nephrology (Carlton). 2013 Mar;18(3):241-2. doi: 10.1111/j.1440-1797.2012.01649.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anti-Obesity Agents / adverse effects*
  • Biopsy
  • Diet / adverse effects*
  • Female
  • Humans
  • Hyperoxaluria / chemically induced*
  • Hyperoxaluria / diagnosis
  • Hyperoxaluria / metabolism
  • Hyperoxaluria / therapy
  • Intestinal Mucosa / metabolism
  • Intestines / drug effects*
  • Kidney / drug effects*
  • Kidney / metabolism
  • Kidney / pathology
  • Kidney Diseases / chemically induced*
  • Kidney Diseases / metabolism
  • Kidney Diseases / pathology
  • Kidney Diseases / therapy
  • Lactones / adverse effects*
  • Middle Aged
  • Orlistat
  • Oxalic Acid / adverse effects*
  • Oxalic Acid / metabolism
  • Rheum / adverse effects
  • Spinacia oleracea / adverse effects

Substances

  • Anti-Obesity Agents
  • Lactones
  • Orlistat
  • Oxalic Acid